Breast Cancer Res. 2002;4(1):24-9. Epub 2001 Nov 26.

The present and future role of bisphosphonates in the management of patients with breast cancer.

Source

Yorkshire Cancer Research Academic Unit of Clinical Oncology, Cancer Research Centre, Weston Park Hospital, Sheffield, UK.

Abstract

At least 25% of patients with breast cancer develop skeletal metastases, with bone the site of disease producing the greatest morbidity. It is apparent that the bisphosphonates present an important component of the treatment strategy. They are now the treatment of choice in tumour-induced hypercalcaemia, and they can reduce bone pain and skeletal complications such as pathological fractures. In addition, bisphosphonates are being increasingly evaluated in the prevention of bone metastases and to prevent and treat cancer therapy-induced osteoporosis. Ongoing research is aimed at trying to define the optimum route, dose, schedule and type of bisphosphonate.

PMID:: 11879556; [PubMed - indexed for MEDLINE]
PMCID: PMC138712

Free PMC Article

Images from this publication.See all images (1) Free text

Publication Types, MeSH Terms, Substances

Publication Types

Review

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Medical

Libraries

LinkOut Holdings

Supplemental Content

Related citations

Review Bisphosphonates for breast cancer. [Cochrane Database Syst Rev. 2005]
Review Bisphosphonates for breast cancer.
Pavlakis N, Schmidt R, Stockler M. Cochrane Database Syst Rev. 2005 Jul 20; (3):CD003474. Epub 2005 Jul 20.
Optimising treatment of bone metastases by Aredia(TM) and Zometa(TM). [Breast Cancer. 2000]
Optimising treatment of bone metastases by Aredia(TM) and Zometa(TM).
Coleman RE. Breast Cancer. 2000; 7(4):361-9.
Review The role of bisphosphonates in breast and prostate cancers. [Endocr Relat Cancer. 2004]
Review The role of bisphosphonates in breast and prostate cancers.
Brown JE, Neville-Webbe H, Coleman RE. Endocr Relat Cancer. 2004 Jun; 11(2):207-24.
Review Bisphosphonates in the prevention and treatment of bone metastases. [Oncology (Williston Park). 2003]
Review Bisphosphonates in the prevention and treatment of bone metastases.
Ramaswamy B, Shapiro CL. Oncology (Williston Park). 2003 Sep; 17(9):1261-70; discussion 1270-2, 1277-8, 1280.
Role of bisphosphonates in prevention and treatment of bone metastases from breast cancer. [Can J Oncol. 1995]
Role of bisphosphonates in prevention and treatment of bone metastases from breast cancer.
Paterson AH, Kanis JA, Powles TJ, McCloskey E, Hanson J, Ashley S. Can J Oncol. 1995 Dec; 5 Suppl 1:54-7.

See reviews... See all...

Cited by 1 PubMed Central article

A short account of metastatic bone disease. [Cancer Cell Int. 2011]
A short account of metastatic bone disease.
Feller L, Kramer B, Lemmer J. Cancer Cell Int. 2011 Jul 27; 11:24. Epub 2011 Jul 27.

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
References for this PMC Article
Citation referenced in PubMed article. Only valid for PubMed citations that are also in PMC.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Free in PMC
Free full text articles in PMC
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

The present and future role of bisphosphonates in the management of patients wit...
The present and future role of bisphosphonates in the management of patients with breast cancer.
Breast Cancer Res. 2002 ;4(1):24-9. Epub 2001 Nov 26 .

PubMed
Study of messenger RNA inactivation and protein degradation in an Escherichia co...
Study of messenger RNA inactivation and protein degradation in an Escherichia coli cell-free expression system.
J Biol Eng. 2010 Jul 1 ;4:9.

PubMed
Efficient cell-free expression with the endogenous E. Coli RNA polymerase and si...
Efficient cell-free expression with the endogenous E. Coli RNA polymerase and sigma factor 70.
J Biol Eng. 2010 Jun 24 ;4:8.

PubMed
More insights into the immunosuppressive potential of tumor exosomes.
More insights into the immunosuppressive potential of tumor exosomes.
J Transl Med. 2008 Oct 30 ;6:63.

PubMed
Regulatory T cells in rheumatoid arthritis.
Regulatory T cells in rheumatoid arthritis.
Arthritis Res Ther. 2005 ;7(3):93. Epub 2005 Mar 9 .

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Display Settings:

Send to: